UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000017552
Receipt number R000019474
Scientific Title A phase II clinical trial (KSCC/HGCSG/CCOG/PerSeUS1501B) examining oxaliplatin + S-1 + trastuzumab for treatment of HER2-positive advanced/recurrent gastric cancer previously untreated with chemotherapy
Date of disclosure of the study information 2015/05/29
Last modified on 2019/01/06 17:25:55

No. Disposal Last modified on Item of update
1 Insert 2015/05/13 22:45:41
2 Update 2015/05/22 10:16:32 Public title
Public title
Acronym
Acronym
3 Update 2015/05/22 10:17:14 Email
Email
4 Update 2015/05/22 16:09:47 Institutions
5 Update 2015/05/22 16:10:26 UMIN ID1
6 Update 2015/05/29 10:08:54 Date of disclosure of the study information
7 Update 2015/05/29 10:42:39 Institutions
8 Update 2015/05/29 17:08:32 Last name of contact person
Last name of contact person
Organization
Organization
Division name
Division name
Address
Address
Email
9 Update 2015/06/17 11:50:42 Recruitment status
10 Update 2015/11/13 15:03:11 Institutions
11 Update 2015/12/13 12:20:07 Institutions
12 Update 2016/02/24 18:58:45 Acronym
Acronym
13 Update 2016/05/13 09:06:58 Key inclusion criteria
Key exclusion criteria
14 Update 2016/05/13 09:24:19 Name of primary person or sponsor
Organization
Institutions
15 Update 2016/05/13 10:05:17 Institutions
16 Update 2016/05/13 10:13:47 Recruitment status
17 Update 2019/01/06 17:25:55 Recruitment status
Publication of results
Results
Results